Patents Assigned to Pulmonx
  • Publication number: 20070043350
    Abstract: Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.
    Type: Application
    Filed: July 28, 2006
    Publication date: February 22, 2007
    Applicant: PULMONx
    Inventors: Peter Soltesz, Nikolai Aljuri, Ajit Nair
  • Patent number: 7141046
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: December 13, 2001
    Date of Patent: November 28, 2006
    Assignee: Pulmonx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Publication number: 20060264772
    Abstract: Minimally invasive methods, systems and devices are provided for qualitatively and quantitatively assessing collateral ventilation in the lungs. In particular, collateral ventilation of a target compartment within a lung of a patient is assessed by advancement of a catheter through the tracheobronchial tree to a feeding bronchus of the target compartment. The feeding bronchus is occluded by the catheter and a variety of measurements are taken with the use of the catheter in a manner which is of low risk to the patient. Examples of such measurements include but are not limited to flow rate, volume and pressure. These measurements are used to determine the presence of collateral ventilation and to quantify such collateral ventilation.
    Type: Application
    Filed: December 7, 2005
    Publication date: November 23, 2006
    Applicant: PULMONX
    Inventors: Nikolai Aljuri, Anthony Wondka, George Surjan, Kirk Davis, Peter Soltesz, Rodney Perkins
  • Publication number: 20060162731
    Abstract: Methods, systems and devices are provided for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung and occluding various lung passageways with the use of occlusal stents. The occlusal stents are delivered with the use of an occlusal stent delivery system which is loaded with the occlusal stent with the use of an occlusal stent loading system.
    Type: Application
    Filed: November 15, 2005
    Publication date: July 27, 2006
    Applicant: PULMONx
    Inventors: Anthony Wondka, Peter Soltesz, Robert Kotmel, Nadia Matov, Thomas Crowder
  • Publication number: 20060135947
    Abstract: Improved methods, systems and devices for occluding body passageways, particularly lung passageways. Such occlusion is achieved with occlusal stents which are particularly suited for use in performing Endobronchial Volume Reduction (EVR) in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The present invention is likewise suitable for the treatment of bronchopleural fistula and potentially for other pulmonary diseases, such as hemoptysis and pneumothorax. The occlusal stents are delivered with the use of any suitable delivery system, particularly minimally invasive with instruments introduced through the mouth (endotracheally). A target lung tissue segment is isolated from other regions of the lung by deploying an occlusal stent into a target area of a lung passageway. A variety of different occlusal stent designs are provided to improve the performance and reliability of the delivered occlusal stent.
    Type: Application
    Filed: November 15, 2005
    Publication date: June 22, 2006
    Applicant: PULMONx
    Inventors: Peter Soltesz, Anthony Wondka, Jeffrey Lee, Robert Kotmel
  • Publication number: 20060095002
    Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.
    Type: Application
    Filed: November 9, 2005
    Publication date: May 4, 2006
    Applicant: PULMONx
    Inventors: Peter Soltesz, Robert Kotmel, Tony Wondka, Michael Reilly, Wally Buch
  • Patent number: 6997918
    Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.
    Type: Grant
    Filed: March 4, 2003
    Date of Patent: February 14, 2006
    Assignee: Pulmonx
    Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
  • Publication number: 20050203483
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Application
    Filed: April 12, 2005
    Publication date: September 15, 2005
    Applicant: PULMONx
    Inventors: Rodney Perkins, Peter Soltesz, Robert Kotmel, Anthony Wondka
  • Patent number: 6878141
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: April 12, 2005
    Assignee: Pulmonx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel, Anthony D. Wondka
  • Publication number: 20050061322
    Abstract: The invention relates to a method and an arrangement for reducing the volume of a patient's lung. A bronchial catheter (2) is introduced into a hyperexpanded lung area, and air is aspirated from there by means of an aspiration device (3). The associated segmental bronchus is then closed. According to the invention, the patient's spontaneous respiration is recorded by sensors (5), and aspiration of the air is carried out in synchrony with the patient's inhalation action. In order to prevent collapse of the associated segmental bronchus, a pressure generator is provided with which the associated segmental bronchus can be widened, by a compressed gas pulse, in synchrony with the aspiration. The pressure generator can be activated as a function of the aspirated air stream, which is monitored with a measuring device.
    Type: Application
    Filed: November 3, 2004
    Publication date: March 24, 2005
    Applicant: PULMONx
    Inventor: Lutz Freitag
  • Publication number: 20050015106
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Application
    Filed: August 20, 2004
    Publication date: January 20, 2005
    Applicant: PULMONx
    Inventors: Rodney Perkins, Peter Soltesz, Robert Kotmel
  • Publication number: 20040158228
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Application
    Filed: January 26, 2004
    Publication date: August 12, 2004
    Applicant: PULMONx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Publication number: 20040073191
    Abstract: The present invention provides improved methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions where isolation of a lung segment or reduction of lung volume is desired. The methods are minimally invasive with instruments being introduced through the mouth (endotracheally) and rely on isolating the target lung tissue segment from other regions of the lung. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port.
    Type: Application
    Filed: March 4, 2003
    Publication date: April 15, 2004
    Applicant: PULMONx
    Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
  • Patent number: 6709401
    Abstract: Lung volume reduction is performed in a minimally invasive manner by isolating a lung tissue segment, optionally reducing gas flow obstructions within the segment, and aspirating the segment to cause the segment to at least partially collapse. Further optionally, external pressure may be applied on the segment to assist in complete collapse. Reduction of gas flow obstructions may be achieved in a variety of ways, including over inflation of the lung, introduction of mucolytic or dilation agents, application of vibrational energy, induction of absorption atelectasis, or the like. Optionally, diagnostic procedures on the isolated lung segment may be performed, typically using the same isolation/access catheter.
    Type: Grant
    Filed: July 2, 2001
    Date of Patent: March 23, 2004
    Assignee: Pulmonx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Patent number: 6585639
    Abstract: Apparatus, methods, and kits, are provided for use in combination with a conventional bronchoscope or other lung viewing scope. In particular, sheaths having an inflatable cuff at their distal end are provided to receive a viewing scope through a lumen thereof. The sheaths thus provide an inflatable cuff on a viewing scope assembly so that the scope can be used in procedures which require selective isolation of regions of a patient's lungs. In particular embodiments, the sheaths may include stop elements for properly positioning a viewing scope therein, pressure transducers for providing accurate lung pressure information during procedures, and the like. Methods for using and forming sheaths having inflatable cuffs are also described.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: July 1, 2003
    Assignee: Pulmonx
    Inventors: Robert Kotmel, Hiep Nguyen
  • Publication number: 20030051733
    Abstract: The present invention provides systems, methods, devices and kits for assessing the level of pulmonary disease in individual lung compartments. A lung compartment comprises a subportion of a lung, such as a lobe, a segment or a subsegment, for example. By measuring individual lung compartments, the level of disease of the pulmonary system may be more precisely defined by determining values of disease parameters reflective of individual subportions or compartments of a lung. Likewise, compartments may be separately imaged to provide further measurement information. Once individual compartments are characterized, they may be compared and ranked based on a number of variables reflecting, for example, level of disease or need for treatment. Such comparison may be aided by simultaneous display of such variables or images on a visual display. Further, the same tests may be performed on the lung as a whole or on both lungs and to determine the affect of the diseased lung compartments on the overall lung performance.
    Type: Application
    Filed: September 10, 2002
    Publication date: March 20, 2003
    Applicant: Pulmonx
    Inventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
  • Publication number: 20030055331
    Abstract: Devices and methods are provided for acquiring and analyzing an image data file to generate diagnostic information reflecting an individual lung compartment. A lung compartment could be an entire lobe, a segment or a subsegment and beyond, hereinafter subsegments and beyond will be referred to simply as segments. Such analysis is used to assess the level of disease of individual lung compartments, both for quantification of the disease state and for determining the most appropriate treatment plan. This analysis allows the imaging technology to be used as a functional diagnostic tool as well as an anatomical diagnostic tool. To this end, dynamic data or images may also be acquired at specific points throughout the breathing cycle. Since air movement in and out of a lung compartment during the breathing cycle is a direct indicator of lung function in some diseases like emphysema, analysis of images during the breathing cycle will indicate levels of disease.
    Type: Application
    Filed: September 11, 2002
    Publication date: March 20, 2003
    Applicant: PULMONx
    Inventors: Robert Kotmel, Peter Soltesz, Anthony Wondka, Rodney Perkins
  • Patent number: 6527761
    Abstract: Methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions using and comprising minimally invasive instruments introduced through the mouth (endotracheally) to isolate a target lung tissue segment from other regions of the lung and reduce lung volume. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: March 4, 2003
    Assignee: Pulmonx, Inc.
    Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch
  • Publication number: 20020077593
    Abstract: Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.
    Type: Application
    Filed: February 11, 2002
    Publication date: June 20, 2002
    Applicant: PULMONX
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel
  • Patent number: 6398775
    Abstract: Apparatus, systems, methods, and kits are provided for isolating a target lung segment and treating that segment, usually by drug delivery or lavage. The systems include at least a lobar or sub-lobar isolation catheter which is introduced beyond a second lung bifurcation (i.e., beyond the first bifurcation in a lobe of the lung) and which can occlude a bronchial passage at that point. An inner catheter is usually introduced through the isolation catheter and used in cooperation with the isolation catheter for delivering and/or removing drugs or washing liquids from the isolated lung region. Optionally, the inner catheter will also have an occluding member near its distal end for further isolation of a target region within the lung.
    Type: Grant
    Filed: October 21, 1999
    Date of Patent: June 4, 2002
    Assignee: Pulmonx
    Inventors: Rodney A. Perkins, Peter P. Soltesz, Robert Kotmel